Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Units to Offer Affymetrix's New DMET Services

NEW YORK (GenomeWeb News) — Affymetrix today launched its Drug Metabolizing Enzymes and Transporters early-access service program and announced that two units of Clinical Data would provide the services worldwide.
 
Affymetrix is initially launching the pharmacogenomics DMET panel as a service, which also is available through its clinical lab service in South San Francisco. The firm has said that it intends to offer the DMET panel as a catalogue product this year.
 
The panel was originally developed by ParAllele Bioscience and Eli Lilly and was scheduled to become commercially available in the third quarter of 2005. However, after Affy acquired ParAllele that year, the project was delayed as the company focused on launching a series of arrays for whole-genome genotyping.
 
Affy said that its panel is the “only product available with comprehensive coverage of all ADME drug metabolism biomarkers, including common and rare variations, insertions, deletions, copy number, triallelic SNPs, and pseudogenes.”
 
The alliance with Clinical Data allows its Cogenics and Epidauros Biotechnologie subsidiaries to offer the DMET service, with limited exclusive rights in Europe. Cogenics worked with Affy on development of the panel, which includes a total of 1,069 drug metabolism biomarkers.
 
Affy officials believe the service will be a major cost saver for the pharma industry, with adverse drug events costing $4 billion a year alone.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.